Section for Clinical Epidemiology

​Section for Clinical Epidemiology conduct epidemiological research on both patient and population-based studies and national registry cohorts. These studies involve prevention, diagnosis, treatment, prognosis and postmarketing medicinal research.

Research Focus

  1. Early life body size and growth in relation to health 
    Associate Professor and Senior Researcher Jennifer L. Baker leads the group “Life Course Epidemiology of Growth and Health" in the section for Clinical Epidemiology. A substantial part of the work in her group uses the data resource of the Copenhagen School Health Records Register which contains measures of height and weight on 405,000 school children born from 1930-1996. Though linkages with national health registers, cohort studies and databases, this resource supports studies examining how childhood body size and growth, alone and in conjunction with adult size, relate to the risks of cardiovascular disease, cancer, type 2 diabetes, as well as many other diseases. Another key data resource used by the group is the Infant Health Visitor Records Register which contains information on approximately 95,000 infants born from 1958-1967. Again, through linkages with other data resources Jennifer and her group members investigate how early life growth and nutrition are related to health later in life. 

  2. Gastroenterological and endocrinological epidemiology
    This group studies how, and if, inflammatory bowel disease, intestinal microbiota and hormones contribute to the development of cardiometabolistic diseases  such as obesity, type 2 diabetes and cardiovascular disease. The research is based on data from the center's population-based cohorts, the national health registries and also laboratory research.

  3. Postmarketing medicinal research/ phase IV medicinal research
    This group focuses on the study of medicine's effectiveness and side effects, after it has been approved and applied in the general population. Phase IV studies are valuable since they more rigorously develop an understanding of the effectiveness and side effects when applied in a complicated real situation. The center's experience and strenght in national health registries gives the group a unique ability to do phase IV studies of the highest international standard.

  4. Scientific support to clinicians
    We offer scientific support to clinicians in the Capital Region. The group is especially well practiced in methodology and actively help with everything from fund applications and study design to data handling, statistics and writing support.Johan Michael Burisch

Research Partners

Section for Clinical Epidemiology has a close partnership with the clinical departments in the Capital Region. We also have numerous collaborations both nationally and internationally. Central national academic partners include the Novo Nordisk Foundation Center for Basic Metabolic Research at University of Copenhagen, where Jennifer L. Baker and Kristine Allin are associated as associate professors and Steno Diabetes Center Copenhagen. Our international partners include Imperial College London, Harvard University, Cornell University, National Cancer Institute, Mayo Clinic and Mount Sinai (USA).

Resources and equipment

In Section for Clinical Epidemiology we use epidemiological and statistical methods on our own data and data from the national registries through Statistics Denmark and Sundhedsdatastyrelsen. We use SAS, R and Stata statistical software. We also collaborate with the Novo Nordisk Foundation Center for Basic Metabolic Research at University of Copenhagen who has a molecular/genetic laboratory.

Responsible editor